Jane Street Group, LLC 9 Meters Biopharma, Inc. Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$0.52 - $1.0 $13,006 - $25,013	-25,013 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$0.85 - $1.33 $100,644 - $157,478	-118,405 Reduced 82.56%	25,013 $25,000
Q3 2021 Nov 16, 2021	SELL	$1.03 - $1.41 $258,921 - $354,445	-251,380 Reduced 63.67%	143,418 $186,000
Q2 2021 Aug 16, 2021	BUY	$1.04 - $1.5 $293,586 - $423,442	282,295 Added 250.92%	394,798 $434,000
Q1 2021 May 18, 2021	BUY	$0.84 - $2.16 $94,502 - $243,006	112,503 New	112,503 $132,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.